Cargando…
lncRNA NORAD promotes the progression of osteosarcoma via targeting of miR-155-5p
Osteosarcoma (OS) is the most common malignant bone tumor in teens. Non-coding RNA activated by DNA damage (NORAD), a long non-coding RNA (lncRNA), has been reported to be involved in cancer biology, although its role in OS remains largely unknown. In the present study reverse transcription-quantita...
Autores principales: | Wang, Ye, Zhou, Bin, Yan, Liping, Wu, Jianhui, Xing, Zhijie, Zhang, Shaochun, Xiang, Fusheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8097224/ https://www.ncbi.nlm.nih.gov/pubmed/33968176 http://dx.doi.org/10.3892/etm.2021.10077 |
Ejemplares similares
-
lncRNA NORAD Contributes to Colorectal Cancer Progression by Inhibition of miR-202-5p
por: Zhang, Jie, et al.
Publicado: (2018) -
LncRNA NORAD promotes the progression of myocardial infarction by targeting the miR-22-3p/PTEN axis: NORAD promotes myocardial infarction via miR-22-3p/PTEN
por: Li, Chunxia, et al.
Publicado: (2022) -
LncRNA NORAD facilitates oral squamous cell carcinoma progression by sponging miR-577 to enhance TPM4
por: Qi, Change, et al.
Publicado: (2022) -
Diagnostic implications of lncRNA NORAD in breast cancer
por: Zhang, Yaping, et al.
Publicado: (2023) -
lncRNA NORAD promotes lung cancer progression by competitively binding to miR-28-3p with E2F2
por: Mao, Wenjun, et al.
Publicado: (2022)